*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Betahistine EP Impurity A serves as a critical reference standard for quality control in the pharmaceutical industry, specifically monitoring degradation pathways during the synthesis of Betahistine dihydrochloride. This compound is chemically identified by the molecular formula <strong>C9H15N3O2S</strong> and CAS number <strong>10074-86-3</strong>. It is produced via precise oxidative coupling processes to ensure high purity levels compliant with European Pharmacopoeia specifications.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Assurance:</strong> Used as an analytical standard to validate HPLC methods for detecting trace impurities in active pharmaceutical ingredients.</li>
<li><strong>R&D Testing:</strong> Employed in stability studies to evaluate the long-term shelf life and degradation kinetics of Betahistine formulations.</li>
<li><strong>Regulatory Compliance:</strong> Essential for generating data required for regulatory filings with agencies like EMA and FDA regarding impurity profiles.</li>
</ul>
<h3>Precautions</h3>
<p>This substance must be stored in sealed containers at temperatures below <strong>-20°C</strong> under inert atmosphere to prevent hydrolysis. Handling requires appropriate PPE including nitrile gloves and safety goggles to avoid skin contact or inhalation of dust particles.</p>